| Not Yet Recruiting | Efficacy and Safety of Microtransplantation for Advanced and Relapsed Solid Tumors Advanced and Relapsed Solid Tumors | Phase 1 | 2026-01-15 |
| Unknown | Microtransplantation for Ovarian Cancer Ovarian Cancer Recurrent | Phase 1 / Phase 2 | 2021-10-01 |
| Unknown | Microtransplantation for Advanced and Relapsed Solid Tumors Solid Tumors | Phase 1 / Phase 2 | 2021-06-01 |
| Unknown | Cord Blood Microtransplantation for Treatment of Acute Myeloid Leukemia Safety Issues, Efficiency | Phase 1 | 2020-01-22 |
| Unknown | CART-123 FOR Relapsed/Refractory Acute Myelocytic Leukemia（AML） Leukemia, Myeloid, Acute | Phase 1 / Phase 2 | 2018-03-01 |
| Unknown | CART-19 FOR Relapsed/Refractory Acute Lymphoblastic Leukemia （ALL） Leukemia, Lymphocytic, Acute | Phase 1 / Phase 2 | 2018-03-01 |
| Unknown | Exploratory Clinical Study of Apatinib and SHR-1210 in Treating Advanced Hepatocellular Carcinoma or Gastric C Gastric Cancer, Hepatocellular Carcinoma | Phase 1 / Phase 2 | 2016-10-01 |
| Unknown | High Dose Donor Hematopoietic Stem Cell Infusion for Relapsed/Refractory AML Leukemia, Myeloid | Phase 1 / Phase 2 | 2016-03-01 |
| Unknown | Allogeneic CART-33 for Relapsed/Refractory CD33+ AML Relapsed and/or Refractory CD33+ AML | Phase 1 | 2015-10-01 |
| Unknown | Allogeneic CART-19 for Elderly Relapsed/Refractory CD19+ ALL Leukemia | Phase 1 | 2015-10-01 |
| Unknown | Apatinib as Maintenance Therapy After First Line Treatment in Locally Advanced or Metastatic Gastric Cancer Gastric Cancer | Phase 3 | 2015-07-01 |
| Unknown | RhGM-CSF as Adjuvant Immunotherapy in Treating Stage III Colon Cancer Colon Cancer | Phase 2 | 2015-06-01 |
| Unknown | Recombinant Anti-tumor and Anti-virus Protein for Injection to Treat Advanced Neuroendocrine Tumors Neuroendocrine Tumors | Phase 2 | 2015-05-01 |
| Unknown | Safety and Efficacy Study of Microtransplantation to Treat Elderly Acute Myeloid Leukemia Acute Myeloid Leukemia | Phase 3 | 2014-03-01 |
| Unknown | Recombinant Anti-tumor and Anti-virus Protein for Injection Plus Xeloda in Treatment of Metastatic Colorectal Metastatic Colorectal Cancer | Phase 2 | 2014-02-01 |
| Unknown | Paclitaxel Plus Radiation With Erlotinib to Treat Esophageal Squamous Carcinoma Esophageal Squamous Carcinoma | Phase 3 | 2012-11-01 |
| Completed | Individual Dosage Selection of Irinotecan (CPT-11) Based on UGT1A1 Genotype in Metastatic Colorectal Cancer Pa Metastatic Colorectal Cancer | Phase 2 / Phase 3 | 2012-03-08 |
| Unknown | Study of S1 Efficacy and Toxicity as Second-line Treatment on Inoperable or Advanced Gastric Cancers Gastric Cancer | — | 2012-02-01 |
| Unknown | Taxanes or Platinum in Combination With Capecitabine Followed by Capecitabine Alone as First Line Treatment fo Gastric Cancer | Phase 3 | 2011-11-01 |
| Unknown | HLA-mismatched Microtransplantation for High Risk Acute Myeloid Leukemia Acute Myeloid Leukemia | Phase 3 | 2011-08-01 |
| Completed | Recombinant Anti-tumor and Anti-virus Protein for Injection in Treatment of Metastatic Colorectal Cancer Metastatic Colorectal Cancer | Phase 2 | 2011-05-01 |
| Unknown | Study of S-1 as Second Line Treatment on Advanced Pancreatic Cancers Pancreatic Cancer | Phase 2 | 2010-02-01 |
| Completed | Microtransplantation With Decitabine and Cytarabine Improves Patient Outcomes in Myelodysplastic Syndromes Myelodysplastic Syndromes | Phase 1 / Phase 2 | 2009-09-01 |
| Completed | Microtransplantation in Older Patients With Acute Myeloid Leukemia Acute Myeloid Leukemia | Phase 2 | 2006-05-01 |
| Completed | HLA-mismatched MST vs HLA-matched NST for AML in Intermediate-risk Acute Myeloid Leukemia | Phase 3 | 2004-05-01 |